Ziprasidone Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
DLA Troop Support has awarded contract SPE2D2-25-D-0004 to GSMS, Inc. for the supply of Ziprasidone capsules in 20MG, 40MG, 60MG, and 80MG dosages. The contract has a total estimated value of $36,283,048.66, covering a base year and four option years. The pharmaceutical products are manufactured by Apotex, Inc. in Toronto, Ontario, Canada, with packaging and packing handled by Golden State Medical Supply, Inc. in California. The agreement includes fixed annual price increases across all dosage levels and mandates strict adherence to federal acquisition regulations. Key compliance requirements include DFARS cybersecurity standards for safeguarding defense information, supply chain security restrictions regarding covered foreign entities and applications, and the implementation of a Small Business Subcontracting Plan. The contract also incorporates standard labor laws, whistleblower protections, and reporting obligations for executive compensation and first-tier subcontract awards.
General Info
Contract Value
$36,283,048.66Place of Performance
Toronto, CA-ON, CANSet-Aside
Award Issued Date
Timeline
Organization & Contact Information
Full Description
Award for Ziprasidone Capsules SPE2D2-25-D-0004
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
